UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO
Feb 2 (Reuters) - Braeburn Pharmaceuticals Inc, the maker of the first long-acting implant to treat opioid addiction in the United States, said on Thursday that it had decided to withdraw its initial public offering, citing current market conditions. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: Braeburn, maker, implant, addiction, conditions, market, current, citing, offering, public, initial, withdraw its, decided, States, the United, opioid, treat, long-acting, first, of the, Pharmaceuticals, (Reuters), pulls, Pharma, 1-Opioid, UPDATE